An Update on Progress Towards Treating Atherosclerosis at Cyclarity – Fight Aging!

[ad_1] Today I’ll point out an interview with one of the Cyclarity Therapeutics founders, illustrative of the degree to which biotech companies are at the mercy of regulators once they arrive at the clinical stage of development. Cyclarity, formerly Underdog Pharmaceuticals, is a spin-out from the SENS Research Foundation, … Read more